Skip to main content
Journal cover image

Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism.

Publication ,  Journal Article
Adam, MA; Untch, BR; Danko, ME; Stinnett, S; Dixit, D; Koh, J; Marks, JR; Olson, JA
Published in: J Clin Endocrinol Metab
November 2010

CONTEXT: A relationship between primary hyperparathyroidism (PHPT) and obesity has been observed but is incompletely understood. Furthermore, obesity has been associated with vitamin D deficiency, suggesting that the three conditions may be linked. OBJECTIVE: We hypothesized that PHPT in morbidly obese patients is more severe and that the difference may be explained by vitamin D deficiency. DESIGN AND SETTING, PARTICIPANTS, AND OUTCOME MEASURES: Records of 196 patients with surgically treated PHPT and known body mass index (BMI) were examined. Patients were stratified into three BMI groups: group I (nonobese), BMI < 25 kg/m(2) (n = 54); group II (non-severely obese), BMI 25-34 kg/m(2) (n = 102); and group III (severely obese), BMI 35 kg/m(2) or greater (n = 40). RESULTS: Preoperative PTH levels were higher in group ΙΙΙ compared with group Ι (181 ± 153 vs. 140 ± 80 pg/ml, p = 0.04). Group III patients had larger tumors on average compared with group I (1.8 ± 1.5 vs. 1.04 ± 1.5 g, P = 0.0002). In group III, BMI positively correlated with parathyroid tumor weight (r = 0.5, P = 0.002). Postoperative PTH was higher in group III compared with group Ι (61 ± 41 vs. 44 ± 28 pg/ml, P = 0.02). There was higher frequency of depression, musculoskeletal symptoms, weakness, and gastroesophageal reflux disease in group III patients. CONCLUSIONS: BMI positively correlated with parathyroid tumor weight independent of vitamin D. Severely obese patients have larger parathyroid tumor weight, higher pre- and postoperative PTH, and greater symptoms.

Duke Scholars

Published In

J Clin Endocrinol Metab

DOI

EISSN

1945-7197

Publication Date

November 2010

Volume

95

Issue

11

Start / End Page

4917 / 4924

Location

United States

Related Subject Headings

  • Vitamin D Deficiency
  • Vitamin D
  • Severity of Illness Index
  • Parathyroid Neoplasms
  • Parathyroid Hormone
  • Parathyroid Glands
  • Obesity
  • Medical Records
  • Hyperparathyroidism
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Adam, M. A., Untch, B. R., Danko, M. E., Stinnett, S., Dixit, D., Koh, J., … Olson, J. A. (2010). Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism. J Clin Endocrinol Metab, 95(11), 4917–4924. https://doi.org/10.1210/jc.2010-0666
Journal cover image

Published In

J Clin Endocrinol Metab

DOI

EISSN

1945-7197

Publication Date

November 2010

Volume

95

Issue

11

Start / End Page

4917 / 4924

Location

United States

Related Subject Headings

  • Vitamin D Deficiency
  • Vitamin D
  • Severity of Illness Index
  • Parathyroid Neoplasms
  • Parathyroid Hormone
  • Parathyroid Glands
  • Obesity
  • Medical Records
  • Hyperparathyroidism
  • Humans